University of Paris

About: University of Paris is a education organization based out in Paris, France. It is known for research contribution in the topics: Population & Transplantation. The organization has 102426 authors who have published 174180 publications receiving 5041753 citations. The organization is also known as: Sorbonne.

Dinuclear Complexes with Predictable Magnetic Properties

Abstract: When two paramagnetic transition metal ions are present in the same molecular entity, the magnetic properties can be totally different from the sum of the magnetic properties of each ion surrounded by its nearest neighbors. These new properties depend on the nature and the magnitude of the interaction between the metal ions through the bridging ligands. If both ions have an unpaired electron (e.g. Cu2+ ions), then the molecular state of lowest energy is either a spin singlet or a spin triplet. In the former case, the interaction is said to be antiferromagnetic, in the latter case ferromagnetic. The nature and the order of magnitude of the interaction can be engineered by judiciously choosing the interacting metal ions and the bridging and terminal ligands, and, thus, by the symmetry and the delocalization of the orbitals centered on the metal ions and occupied by the unpaired electrons (magnetic orbitals). The first success in this “molecular engineering” of bimetallic compounds was in the synthesis of a Cu2+VO2+ heterobimetallic complex in which the interaction is purely ferro-magnetic. The same strategy could be utilized for designing molecular ferromagnets, one of the major challenges in the area of molecular materials. Another striking result is the possibility of tuning the magnitude of the interaction through a given bridging network by modifying the nature of the terminal ligands, which, in some way, play the role of “adjusting screws”. By careful selection of the bridging and terminal ligands, a very large antiferro-magnetic interaction can be achieved, even if the metal ions are far away from each other. Some sulfur-containing bridges are especially suitable in this respect.

Immune parameters affecting the efficacy of chemotherapeutic regimens

Abstract: The outcome of chemotherapy can be influenced by the host immune system at multiple levels. Chemotherapy can kill cancer cells by causing them to elicit an immune response or alternatively, by increasing their susceptibility to immune attack. In addition, chemotherapy can stimulate anticancer immune effectors either in a direct fashion or by subverting immunosuppressive mechanisms. Beyond cancer-cell-intrinsic factors that determine the cytotoxic or cytostatic response, as well as the potential immunogenicity of tumor cells, the functional state of the host immune system has a major prognostic and predictive impact on the fate of cancer patients treated with conventional or targeted chemotherapies. In this Review, we surmise that immune-relevant biomarkers may guide personalized therapeutic interventions including compensatory measures to restore or improve anticancer immune responses.

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

Abstract: Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic pulmonary disease, complicating many other respiratory disorders, thought to affect ~240 000 people in Europe. The most common form of CPA is chronic cavitary pulmonary aspergillosis (CCPA), which untreated may progress to chronic fibrosing pulmonary aspergillosis. Less common manifestations include: Aspergillus nodule and single aspergilloma. All these entities are found in non-immunocompromised patients with prior or current lung disease. Subacute invasive pulmonary aspergillosis (formerly called chronic necrotising pulmonary aspergillosis) is a more rapidly progressive infection (<3 months) usually found in moderately immunocompromised patients, which should be managed as invasive aspergillosis. Few clinical guidelines have been previously proposed for either diagnosis or management of CPA. A group of experts convened to develop clinical, radiological and microbiological guidelines. The diagnosis of CPA requires a combination of characteristics: one or more cavities with or without a fungal ball present or nodules on thoracic imaging, direct evidence of Aspergillus infection (microscopy or culture from biopsy) or an immunological response to Aspergillus spp. and exclusion of alternative diagnoses, all present for at least 3 months. Aspergillus antibody (precipitins) is elevated in over 90% of patients. Surgical excision of simple aspergilloma is recommended, if technically possible, and preferably via video-assisted thoracic surgery technique. Long-term oral antifungal therapy is recommended for CCPA to improve overall health status and respiratory symptoms, arrest haemoptysis and prevent progression. Careful monitoring of azole serum concentrations, drug interactions and possible toxicities is recommended. Haemoptysis may be controlled with tranexamic acid and bronchial artery embolisation, rarely surgical resection, and may be a sign of therapeutic failure and/or antifungal resistance. Patients with single Aspergillus nodules only need antifungal therapy if not fully resected, but if multiple they may benefit from antifungal treatment, and require careful follow-up.

Homogenization limits and Wigner transforms

Abstract: We present a theory for carrying out homogenization limits for quadratic functions (called “energy densities”) of solutions of initial value problems (IVPs) with anti-self-adjoint (spatial) pseudo-differential operators (PDOs). The approach is based on the introduction of phase space Wigner (matrix) measures that are calculated by solving kinetic equations involving the spectral properties of the PDO. The weak limits of the energy densities are then obtained by taking moments of the Wigner measure. The very general theory is illustrated by typical examples like (semi)classical limits of Schrodinger equations (with or without a periodic potential), the homogenization limit of the acoustic equation in a periodic medium, and the classical limit of the Dirac equation. © 1997 John Wiley & Sons, Inc.